The seroprevalence of SARS-CoV-2 in patients on haemodialysis.
Viyaasan Mahalingasivam 
;
Laurie Tomlinson ;
(2020)
The seroprevalence of SARS-CoV-2 in patients on haemodialysis.
NATURE REVIEWS NEPHROLOGY, 17 (4).
pp. 225-226.
ISSN 1759-5061
DOI: 10.1038/s41581-020-00379-y
;
Laurie Tomlinson ;
(2020)
The seroprevalence of SARS-CoV-2 in patients on haemodialysis.
NATURE REVIEWS NEPHROLOGY, 17 (4).
pp. 225-226.
ISSN 1759-5061
DOI: 10.1038/s41581-020-00379-y
A new study reports the seroprevalence of SARS-CoV-2 antibodies among a cross-section of patients on haemodialysis and uses these data to estimate seroprevalence in the general US population. Although this study demonstrates the potential of monitoring infectious disease prevalence in dialysis populations, the findings should be interpreted with caution.
-
picture_as_pdf - The seroprevalence of SARS-CoV-2 in patients on haemodialysis.pdf
-
subject - Published Version
-
- Available under Creative Commons: NC-ND 3.0
Downloads